SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $409,000 | +94.8% | 2,441 | +24.5% | 0.00% | +100.0% |
Q1 2020 | $210,000 | -33.3% | 1,960 | -29.5% | 0.00% | -50.0% |
Q4 2019 | $315,000 | -11.0% | 2,781 | -33.6% | 0.00% | 0.0% |
Q3 2019 | $354,000 | +35.6% | 4,186 | +18.1% | 0.00% | 0.0% |
Q1 2019 | $261,000 | -30.0% | 3,543 | -26.3% | 0.00% | -33.3% |
Q3 2018 | $373,000 | +63.6% | 4,810 | +40.0% | 0.00% | +50.0% |
Q2 2018 | $228,000 | +3.2% | 3,436 | -19.1% | 0.00% | 0.0% |
Q1 2018 | $221,000 | -20.5% | 4,246 | -17.3% | 0.00% | -33.3% |
Q3 2016 | $278,000 | +35.0% | 5,135 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $206,000 | – | 5,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |